Eli Lilly (#LLY) has broken ground on a new $6.5 billion manufacturing facility in Houston, Texas, as part of the company’s broader $50 billion U.S. manufacturing expansion. 🔹 Key Highlights 💰 Lilly is investing $6.5B in the new Houston facility. 🧪 The site will manufacture APIs for Foundayo (orforglipron) and other medicines. 🇺🇸 The project supports Lilly’s broader $50B U.S. manufacturing expansion. 👷 The facility is expected to create 600+ high-wage jobs. 🏗️ Construction could support approximately 4,000 jobs. 🤖 Lilly plans to use AI, machine learning, automation and advanced analytics at the facility. 📅 Foundayo’s full global rollout is targeted for 2027. 💡 Why It Matters The Houston investment expands Lilly’s U.S. manufacturing capacity as demand for its medicines grows. The use of AI and automation also highlights Lilly’s focus on modernizing pharmaceutical production alongside its broader domestic manufacturing expansion. 🚀 Start Your 7-Day FREE ThinkSabio Trial https://www.thinksabio.com/ ThinkSabio — Stocks Simplified